What was the exceptional gain in the June quarter?

Indoco recorded a ₹97.34 cr gain from the slump sale of its ophthalmic division to Sunways India, which lifted consolidated net profit to ₹65 cr.

What is the underlying operational performance excluding the one-time gain?

Without the exceptional gain, Indoco reported a pre-exceptional loss at the consolidated level. EBITDA margin was only 10.3%, indicating core operations are under pressure.

What is the auditor's going concern warning about?

The auditor flagged FPP Holding LLC, a subsidiary, with negative net worth of ₹38 cr, creating material uncertainty about its ability to continue as a going concern.

How does Indoco's debt compare to its market cap?

Consolidated debt stood at around ₹960 cr, which is roughly 45% of the company's market capitalization of ₹2,138 cr.

Earnings · Pharmaceuticals · Small cap

Indoco's ₹97 cr sale masks core loss; auditor flags subsidiary's future

June-quarter profit of ₹65 cr is entirely from the ophthalmic division sale. Excluding it, operations are in the red. Auditor material uncertainty on FPP Holding adds another concern.

— 2 earlier stories on Indoco Remedies Ltd. →

INDOCO By Tipsheet Editorial 28 Jul 2026 · 12:56 PM IST Verify on BSE · NSE

Mkt cap₹2,138 cr

ROE0.00%

Debt / eq.0.96

Div yld0.08%

₹97.34 cr One-time gain from ophthalmic slump sale that lifted reported profit

What's new

Reported profit of ₹65 cr includes ₹97 cr one-time gain; underlying operations loss-making.
EBITDA margin at 10.3% with tight liquidity and consolidated debt of ₹960 cr.
Auditor flags FPP Holding's negative net worth of ₹38 cr as going concern uncertainty.

Why this matters

The headline profit is an optical lift from asset sale. Core business is struggling with debt at ₹960 cr and muted growth. The auditor's warning on a subsidiary adds governance risk.

What we're watching

Ability to service debt from operations.
Any recovery in core margins.
Management's plan for FPP Holding.

The full read

Indoco reported ₹65 cr profit for June. That comes entirely from the ophthalmic sale — core operations are in the red. EBITDA margin is just 10.3%, and consolidated debt stands at ₹960 cr, nearly half the company's market capitalisation of ₹2,138 cr. The auditor's review flags FPP Holding's negative net worth of ₹38 cr as a material going concern uncertainty. A red flag. The ophthalmic sale provides cash, but the core business needs to generate profits to service that debt.

Questions answered

What was the exceptional gain in the June quarter?: Indoco recorded a ₹97.34 cr gain from the slump sale of its ophthalmic division to Sunways India, which lifted consolidated net profit to ₹65 cr.
What is the underlying operational performance excluding the one-time gain?: Without the exceptional gain, Indoco reported a pre-exceptional loss at the consolidated level. EBITDA margin was only 10.3%, indicating core operations are under pressure.
What is the auditor's going concern warning about?: The auditor flagged FPP Holding LLC, a subsidiary, with negative net worth of ₹38 cr, creating material uncertainty about its ability to continue as a going concern.
How does Indoco's debt compare to its market cap?: Consolidated debt stood at around ₹960 cr, which is roughly 45% of the company's market capitalization of ₹2,138 cr.

Mentioned: Sunways India · FPP Holding LLC · ₹960 cr debt

Primary source BSE · NSE

An independent reading of the company's own disclosure — the primary filing above is the final word.

Story so far

All notes on INDOCO →

28 Jul 2026 · 12:56 PM IST Indoco's ₹97 cr sale masks core loss; auditor flags subsidiary's future
today Indoco cuts debt target, USFDA audit still open
today Indoco Q1 profit hinges on ₹97 cr ophthalmic sale gain